Corrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections & Amplifications This headline was corrected…
Read more GSK PLC 4Q Pre-items, Pretax Pft GBP1.56BPfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good. Source link
Read more Pfizer Earnings Beat. Guidance Disappoints.By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary endpoint of progression-free…
Read more GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
